Skip to main content

Table 1 Follow-up chart of study participants

From: Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial

Timeline in months

Baseline

4

8

12

Informed consent

X

   

Socio-economic and demographic

X

  

X

History (symptoms)

X

X

X

X

Examination (clinical)

X

  

X

Temperature

X

X

X

X

School achievement

X

  

X

Blood film

X

X

X

X

Hemoglobin (hemocontrol)

X

X

X

X

Thin and thick smear

X

X

X

X

Plasma sample

X

  

X

Filter paper PCR

X

  

X

Stool and urine sample

X

  

X

Malaria treatmentb

X

X

X

X

Anthelminthic treatment

X

Xa

Xa

X

Adverse events

X

X

X

X

Concomitant medications

X

X

X

X

  1. aonly albendazole is given to participants. ball participants will receive SP at Month 12 irrespective of the treatment allocation. In lines: we have the timelines (in months) that are displayed as baseline, month 4, month 8 and month 12. In columns are the study tasks that are performed and the parameters that are collected. X means perform this task. Blank cells mean that the specific activity will not be performed at the corresponding timeline.